450 related articles for article (PubMed ID: 16786344)
1. Induction of cellular immunity against hair follicle melanocyte causes alopecia.
Nagai H; Oniki S; Oka M; Horikawa T; Nishigori C
Arch Dermatol Res; 2006 Aug; 298(3):131-4. PubMed ID: 16786344
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
4. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
[TBL] [Abstract][Full Text] [Related]
6. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles.
Randall VA; Jenner TJ; Hibberts NA; De Oliveira IO; Vafaee T
J Endocrinol; 2008 Apr; 197(1):11-23. PubMed ID: 18372228
[TBL] [Abstract][Full Text] [Related]
8. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
[TBL] [Abstract][Full Text] [Related]
9. CD80CD86 deficiency disrupts regulatory CD4+FoxP3+T cell homoeostasis and induces autoimmune-like alopecia.
Bae JH; Hwang WS; Jang YJ; Lee YH; Jang DE; Kim JS; Yeom SC
Exp Dermatol; 2017 Nov; 26(11):1053-1059. PubMed ID: 28423200
[TBL] [Abstract][Full Text] [Related]
10. Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration.
Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
J Invest Dermatol; 2000 Dec; 115(6):1059-64. PubMed ID: 11121142
[TBL] [Abstract][Full Text] [Related]
11. In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata.
McElwee KJ; Spiers EM; Oliver RF
Br J Dermatol; 1996 Aug; 135(2):211-7. PubMed ID: 8881662
[TBL] [Abstract][Full Text] [Related]
12. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice.
Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
J Invest Dermatol; 2001 Dec; 117(6):1357-62. PubMed ID: 11886495
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy.
Selleri S; Arnaboldi F; Palazzo M; Hussein U; Balsari A; Rumio C
Br J Dermatol; 2005 Sep; 153(3):506-13. PubMed ID: 16120134
[TBL] [Abstract][Full Text] [Related]
14. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?
Paus R; Slominski A; Czarnetzki BM
Yale J Biol Med; 1993; 66(6):541-54. PubMed ID: 7716973
[TBL] [Abstract][Full Text] [Related]
15. Possible role of the bulge region in the pathogenesis of inflammatory scarring alopecia: lichen planopilaris as the prototype.
Mobini N; Tam S; Kamino H
J Cutan Pathol; 2005 Nov; 32(10):675-9. PubMed ID: 16293179
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the bulge region in primary scarring alopecia.
Pozdnyakova O; Mahalingam M
J Cutan Pathol; 2008 Oct; 35(10):922-5. PubMed ID: 18537862
[TBL] [Abstract][Full Text] [Related]
17. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging.
Van Neste D; Tobin DJ
Micron; 2004; 35(3):193-200. PubMed ID: 15036274
[TBL] [Abstract][Full Text] [Related]
18. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
19. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
[TBL] [Abstract][Full Text] [Related]
20. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
Wasyłyszyn T; Kozłowski W; Zabielski SL
Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
